Clinical Trials Browser

Phase 2 × OTHER × Neovascularization, Pathologic × Clear all

NCT07346404 2026-01-16

RUBIKID

Phase 2 Not yet recruiting

Carcinoma, Renal Cell, Neovascularization, Pathologic

NCT01367288 2019-05-28

NEOZOL

Phase 2 Completed

Breast Neoplasms, Neovascularization, Pathologic

NCT00162669 2006-09-08

Bevacizumab in Advanced Hepatocellular Carcinoma

Phase 2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Neovascularization, Pathologic